Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

LaCasce AS, Bociek RG, Sawas A, Caimi P, et al. Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma. Blood 2018 Apr 27. pii: blood-2017-11-815183. doi: 10.1182/blood-2017-11-815183.
PMID: 29703778


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016